BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29064136)

  • 1. Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
    Itokawa M; Miyashita M; Arai M; Dan T; Takahashi K; Tokunaga T; Ishimoto K; Toriumi K; Ichikawa T; Horiuchi Y; Kobori A; Usami S; Yoshikawa T; Amano N; Washizuka S; Okazaki Y; Miyata T
    Psychiatry Clin Neurosci; 2018 Jan; 72(1):35-44. PubMed ID: 29064136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced carbonyl stress in a subpopulation of schizophrenia.
    Arai M; Yuzawa H; Nohara I; Ohnishi T; Obata N; Iwayama Y; Haga S; Toyota T; Ujike H; Arai M; Ichikawa T; Nishida A; Tanaka Y; Furukawa A; Aikawa Y; Kuroda O; Niizato K; Izawa R; Nakamura K; Mori N; Matsuzawa D; Hashimoto K; Iyo M; Sora I; Matsushita M; Okazaki Y; Yoshikawa T; Miyata T; Itokawa M
    Arch Gen Psychiatry; 2010 Jun; 67(6):589-97. PubMed ID: 20530008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonyl stress and schizophrenia.
    Arai M; Miyashita M; Kobori A; Toriumi K; Horiuchi Y; Itokawa M
    Psychiatry Clin Neurosci; 2014 Sep; 68(9):655-65. PubMed ID: 24995521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of schizophrenia with enhanced carbonyl stress.
    Miyashita M; Arai M; Kobori A; Ichikawa T; Toriumi K; Niizato K; Oshima K; Okazaki Y; Yoshikawa T; Amano N; Miyata T; Itokawa M
    Schizophr Bull; 2014 Sep; 40(5):1040-6. PubMed ID: 24062594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.
    Sannohe T; Ohnuma T; Takeuchi M; Tani E; Miki Y; Takeda M; Katsuta N; Takebayashi Y; Nakamura T; Nishimon S; Kimoto A; Higashiyama R; Shibata N; Gohda T; Suzuki Y; Yamagishi SI; Tomino Y; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():42-48. PubMed ID: 28282638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.
    Katsuta N; Ohnuma T; Maeshima H; Takebayashi Y; Higa M; Takeda M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Arai H
    Schizophr Bull; 2014 Nov; 40(6):1366-73. PubMed ID: 24448481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
    Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
    Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
    Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
    Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of modified proteins in plasma from a subtype of schizophrenia based on carbonyl stress: Protein carbonyl is a possible biomarker of psychiatric disorders.
    Koike S; Kayama T; Arai M; Horiuchi Y; Kobori A; Miyashita M; Itokawa M; Ogasawara Y
    Biochem Biophys Res Commun; 2015 Nov; 467(2):361-6. PubMed ID: 26431870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history.
    Toyosima M; Maekawa M; Toyota T; Iwayama Y; Arai M; Ichikawa T; Miyashita M; Arinami T; Itokawa M; Yoshikawa T
    Br J Psychiatry; 2011 Sep; 199(3):245-6. PubMed ID: 21881099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonyl stress in schizophrenia.
    Itokawa M; Miyashita M; Arai M; Miyata T
    Biochem Soc Trans; 2014 Apr; 42(2):468-72. PubMed ID: 24646262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on pathophysiology of schizophrenia with a rare variant as a clue].
    Itokawa M; Arai M; Ichikawa T; Miyashita M; Okazaki Y
    Brain Nerve; 2011 Mar; 63(3):223-31. PubMed ID: 21386123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
    Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
    Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
    Słowik-Zyłka D
    Ann Acad Med Stetin; 2004; 50(2):5-15. PubMed ID: 16529161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.
    Wetzels S; Wouters K; Miyata T; Scheijen JLJM; Hendriks JJA; Schalkwijk CG; Vanmierlo T
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbonyl stress-related schizophrenia--perspective on future therapy and hypotheses regarding pathophysiology of schizophrenia].
    Arai M; Miyashita M; Ichikawa T; Itokawa M
    Seishin Shinkeigaku Zasshi; 2012; 114(3):199-208. PubMed ID: 22568054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenia and carbonyl stress].
    Arai M; Miyashita M; Ichikawa T; Itokawa M
    Seishin Shinkeigaku Zasshi; 2012; 114(2):101-7. PubMed ID: 22568112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.
    Miyashita M; Arai M; Yuzawa H; Niizato K; Oshima K; Kushima I; Hashimoto R; Fukumoto M; Koike S; Toyota T; Ujike H; Arinami T; Kasai K; Takeda M; Ozaki N; Okazaki Y; Yoshikawa T; Amano N; Miyata T; Itokawa M
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):83-4. PubMed ID: 24393354
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
    Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
    Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.